In gene therapy space, there is great interest in discovering new gene editing targets as well as identifying new indications for known targets though exploration of vector biology and studying biological mechanism underlying disease pathology. In this webinar, we will focus on how recently introduced Biomedical KB-AI can enable and accelerate such investigation. QIAGEN Biomedical […]
Back by popular demand, our live, interactive HGMD Professional sessions are designed to help you master the skills needed to navigate and use the industry-leading database like an expert. Offered on two dates—October 16, 2024, and October 23, 2024—these virtual training sessions will show you how to effectively leverage the extensive features and functionalities of HGMD […]
Get to know the RNA-seq Analysis Portal, a cloud-based platform you can access from within QIAGEN Ingenuity Pathway Analysis (IPA) that helps you analyze your RNA-seq expression data. Its predefined analysis pipelines let you calculate expression levels and identify differential expression and significant pathways, regulators, diseases and functions in just a few steps. The graphical […]
Back by popular demand, our live, interactive HGMD Professional sessions are designed to help you master the skills needed to navigate and use the industry-leading database like an expert. This virtual training session will show you how to effectively leverage the extensive features and functionalities of HGMD Professional compared to its public counterpart. Attendees will […]
This webinar will introduce users to the long read support plugin for Oxford Nanopore and PacBio sequencing reads in QIAGEN CLC Genomics Workbench. Participants will learn how to: Download and install needed plugins Import data required for the analysis Perform long read de novo assembly Map reads to a reference and visualize an assembly Use […]
Meet QIAGEN at the Precision Medicine Forum Berlin This year at the 2024 Precision Medicine Forum Berlin, QIAGEN will showcase our barrier-breaking Sample to Insight Oncology solution. Combining targeted DNA and multimodal pan-cancer panels, one of the fastest and cheapest secondary analysis solutions in the market, and industry-leading variant interpretation and reporting software trusted to […]
Meet QIAGEN at the 2024 American Society of Human Genetics (ASHG) Annual Meeting This year at the 2024 American Society of Human Genetics (ASHG) Annual Meeting, QIAGEN will showcase our Sample to Insight solutions for human genetics and inherited disease applications. From digital PCR technologies and actionable exome panels to one of the fastest and cheapest […]
Are you new to QIAGEN Ingenuity Pathway Analysis (IPA) or interested in expanding your skill set? Join us as we learn more on large dataset analysis and knowledge base queries using QIAGEN IPA. You’ll learn how to: Upload multiple dataset types (e.g., RNA-seq, proteomics, metabolomics) and perform interactive core/pathway analysis in IPA Interpret different results, […]
An exclusive hands-on workshop to try QCI Interpret for Oncology For US-based labs interested in learning more about QCI Interpret for Oncology, QIAGEN’s clinical decision support software for variant interpretation and reporting, we are hosting an exclusive, interactive virtual workshop where you can access and demo the software for free. Each attendee will be given […]
Join us for a 90-minute LIVE group session designed to address different technical questions regarding IPA certification. QIAGEN IPA scientists will answer different IPA related technical questions and clarify various topics per requests of IPA certification participants. If possible, please register for this session and let us know your questions by November 4, 2024. Please […]
Learn how to leverage solutions from QIAGEN Digital Insights to discover biomarkers, validate targets, and identify variants. Attendees will learn to: Locate public studies of interest using OmicSoft DiseaseLand Investigate expression of genes of interest across different treatments, disease states, etc. Identify variants of interest for candidate biomarkers and targets using Human Gene Mutation Database […]
Each year, more than 134 million patients experience adverse drug events, causing 2.4 million deaths worldwide. What if there was a better way to develop and prescribe safer, more effective drugs based on the unique genetic information of every individual? In this webinar, learn about a game-changing solution for labs and pharmaceutical companies to rapidly […]
Industry leaders discuss how to improve the speed, precision and cost-effectiveness of clinical exome testing for newborn screening and rare and undiagnosed diseases Clinical exome testing is revolutionizing the diagnosis of rare and inherited diseases. Its ability to quickly pinpoint the genetic causes of complex conditions has made it a critical component of personalized medicine, […]
Watch NowIn this training, you will learn how to analyze viral samples using QIAGEN CLC Genomics Workbench. This webinar will focus on bioinformatics workflows and data interpretation using H5N1 as an example, but similar analysis can be done with other viral and microbial (bacteria, fungus and more) samples. Using viral samples, you will learn how to: […]
Watch NowMore and more biopharma and academic groups are looking to process a large number of samples simultaneously or for a quicker turnaround time. This webinar will introduce a flexible and powerful setup for running your NGS sequence analyses through servers or Amazon Web Services (AWS), depending on user preference. We will demonstrate how CLC Genomics […]
Watch NowThere is a strong interest in the scientific community to use public (GEO, SRA, TCGA, LINCS, etc.) omics (RNA-seq, scRNA-seq, microarray, proteomics, etc.) data for a variety of discoveries. This webinar, aimed at data scientists, bioinformaticians and similar roles in biopharma and academia, explores a comprehensive way of accessing and analyzing high-quality, expertly curated omics […]
Watch NowYou’re invited to attend the 2024 Clinician’s Roundtable, a virtual event where medical directors and oncologists will discuss how to better interpret genomic test results to tailor treatment strategies for cancer patients. As the role of the Molecular Tumor Board (MTB) becomes increasingly important in the implementation of evidence-based precision cancer medicine programs, molecular pathology […]
Watch NowIngenuity Pathway Analysis (IPA), currently cited in tens of thousands of publications and used by a large number of biopharmaceutical companies, is backed by QIAGEN Biomedical KB-HD. Accordingly, biomedical relationships knowledge has practically become required for innovative data- and analytics-driven drug discovery. It powers biomedical knowledge graph analysis, artificial intelligence (AI)-driven target identification and many […]
Watch Now
